In today’s news update we have links on Obama at the Climate Conference, US stocks and cancer drug information.
Obama Tries to Rally U.N. Climate Conference, but Deadlock Persists
COPENHAGEN — President Obama exhorted world leaders today “not to talk, but to act” as they scrambled in the closing hours of a historic U.N. global warming summit to salvage an agreement to curtail greenhouse gas emissions.
Behind the scenes, dozens of presidents and prime ministers worked on a three-page document that they hope will become the lone outcome of the two-week negotiations here.
US Stocks Open Higher, Led By Technology Sector; DJIA Up 43
NEW YORK (Dow Jones)–U.S. stocks opened higher Friday, led by technology stocks as a number of companies within the sector including Research In Motion and Oracle posted quarterly earnings above analysts’ estimates.
The Dow Jones Industrial Average was up 43 points, or 0.4%, to 10351, in early trading. Technology components Microsoft and Hewlett-Packard were among the measure’s best performers, up 0.8% each.
The technology-heavy Nasdaq Composite rose 0.7%. The Standard & Poor’s 500 rose 0.4%, with its technology sector in the lead. Consumer staples stocks made up the only S&P 500 sector in the red.
UPDATE 2-Celgene’s cancer drug Revlimid succeeds in trial
BOSTON, Dec 18 (Reuters) – Celgene Corp (CELG.O) said on Friday that initial results from a clinical trial showed that multiple myeloma patients who took its drug Revlimid following a stem cell transplant had a 58 percent reduction in risk of their disease progressing.
The company’s shares rose 7.2 percent to $54.26 in premarket trading.
Revlimid is already approved in combination with dexamethasone to treat patients with multiple myeloma who have received at least one prior treatment.
Related Posts
